TABLE 1.
Base-case estimate (min/max) | References | |
---|---|---|
Probabilities | ||
Metastasis prevalence | 0.30 (0.15/0.45) | 2,3 |
Ultrasound sensitivity | 0.63 (0.26/0.92) | 5,7 |
Ultrasound specificity | 0.91 (0.44/0.98) | 5,7 |
FNA sensitivity | 0.65 (0.06/0.95) | 5,7 |
FNA specificity | 0.99 (0.90/1.00) | 5,7 |
SLN surgery sensitivity | 0.93 (0.77/0.98) | 6,8–12 |
SLN surgery specificity | 0.99 (0.90/1.00) | 6,8–12 |
Costs | ||
SLN surgery | $10,078 ($6,522/$17,473) | Patient data |
ALND | $11,045 ($7,250/$19,315) | Patient data |
SLN surgery and ALND | $13,321 ($8,402/$23,537) | Patient data |
FNA with imaging guidance | $128 ($64/$512) | Medicare reimbursement |
Ultrasound of breast | $98 ($49/$392) | Medicare reimbursement |
Echo guidance for biopsy | $206 ($103/$824) | Medicare reimbursement |
Cytopathology evaluation for FNA | $142 ($71/$568) | Medicare reimbursement |
ALND axillary lymph node dissection, FNA fine-needle aspiration, SLN sentinel lymph node